Year-End Report 2025 Generic Sweden AB
February 12, 2026
Year-end report 2025
October through December 2025 (compared with the same period the previous year)
- Net sales increased by 3.0% to 49.2 MSEK (47.8 MSEK)
- Gross profit increased by 4.8% to 21.5 MSEK (20.5 MSEK), corresponding to a gross margin of 43.6% (42.9%)
- EBIT decreased by 11.0% to SEK 9.7 million (SEK 10.9 million), corresponding to an EBIT margin of 19.7% (22.7%)
- Earnings per share amounted to SEK 0.65 (SEK 0.74)
- Cash flow from operating activities amounted to 12.6 MSEK (7.6 MSEK)
January through December 2025 (compared with the same period the previous year)
- Net sales increased by 4.1% to 183.7 MSEK (176.4 MSEK)
- Gross profit increased by 12.3% to 81.0 MSEK (72.2 MSEK), corresponding to a gross margin of 44.1% (40.9%)
- EBIT increased by 15.8% to SEK 38.6 million (SEK 33.3 million), corresponding to an EBIT margin of 21.0% (18.9%)
- Earnings per share amounted to SEK 2.52 (SEK 2.22)
- Cash flow from operating activities amounted to 39.7 MSEK (24.1 MSEK)
- Proposed dividend: 1.75 SEK (1.60 SEK) per share
Note
Generic Sweden AB (publ) is required to disclose this information in accordance with the EU Market Abuse Regulation.
The information was submitted by Jenny Björk for publication at 7:00 a.m. on February 12, 2026.
Jenny Björk
CFO
08-601 38 00
jenny.bjork@generic.se
About Generic
Generic is a technology company operating in the field of messaging services across all sectors. Generic offers a platform for digital communication services that can be integrated into customers’ internal or external communication flows. The services are provided through a CPaaS (Communication Platform as a Service) model with the highest standards of security and reliability. Generic’s customers span all sectors, with a particular focus on alarm and security, healthcare and e-health, as well as e-commerce and logistics. The company was founded in 1993 and is headquartered in Stockholm. Generic reported revenue of approximately 185 MSEK in 2025 and has 22 employees. The stock is traded on the NASDAQ First North Growth Market under the ticker symbol GENI. Mangold Fondkommission AB is the company’s Certified Adviser. 08/503 015 50. ca@mangold.se. Reference is made to www.generic.se/finansiellarapporter. Additional information about the company is available at www.generic.se